TOPLINE:
Most inflammatory bowel disease (IBD) therapies — particularly biologic agents — appear safe in patients with...
Chronic kidney disease (CKD) is widely understood to be associated with cognitive impairment, yet the problem remains...
Please enable Javascript
As <astro-island uid="Z1QMA3U" prefix="r61" component-url="/_astro/external-link.BAH56xi9.js" component-export="default" renderer-url="/_astro/client.4AZqD4Tw.js" props="{"value":[0,{"_type":[0,"@span"],"_key":[0,"7313189a508c"],"children":[1,[[0,{"_type":[0,"@text"],"text":[0,"obesity"]}]]],"markDef":[0,{"_key":[0,"74c4ef4249bc"],"_type":[0,"link"],"blank":[0,true],"href":[0,"https://www.hcplive.com/clinical/obesity-management"],"nofollow":[0,true]}],"markType":[0,"link"],"markKey":[0,"74c4ef4249bc"]}]}" ssr=""...
Recent research published in Stem Cell Reports shows that apolipoprotein L1 (APOL1) mutations impair mitochondrial...
A multicenter, randomized phase 2 clinical trial reported that lubiprostone, a medication typically prescribed for...
TOPLINE:
Patients with chronic kidney disease (CKD) showed a 2.6-fold higher risk for depression requiring antidepressant treatment...
